集束化护理在下呼吸道多重耐药菌定植气管切开患者中的应用效果分析

Analysis of Application Effect of Cluster Nursing in Patients with Lower Respiratory Tract Multidrug-resistant Bacteria Colonized Tracheotomy

目的探讨集束化护理在下呼吸道多重耐药菌定植气管切开患者中的应用效果。方法方便选取2018年2月-2019年2月该院收治的住院并行切管切开的患者80例,经过确诊合并多重耐药菌定值,将患者随机数字表决法分为对照组和观察组各40例。对照组实施常规护理,观察组实施集束化护理。比较护理干预3周后,是否肺部感染,统计患者入住神经外科重症监护室的时间和住院时间,对比整个治疗费用。结果观察组在护理后肺部感染发生率5.00%(2/40),对照组肺部感染发生率27.50%(11/40),观察组相较于对照组降低(χ~2=4.485,P<0.05);观察组入住ICU时间(7.50±1.55)d,住院时间(13.50±1.50)d,住院费用(1.25±0.25)万元,时间相较于对照组缩短(t=9.945、10.585,P<0.05),费用也明显较对照组减少(t=6.887,P<0.05)。结论集束化护理干预用于下呼吸道多重耐药菌定值气管切开患者中,能显著降低患者肺部感染的概率,缩短康复时间,减少住院费用,效果非常显著,具有积极推广价值。

Objective To explore the application effect of cluster nursing in patients with lower respiratory tract multidrugresistant bacteria colonized tracheotomy. Methods A total of 80 hospitalized patients with concurrent catheterization from February 2018 to February 2019 were convenienty selected in the hospital, and 40 patients were divided into control group and observation group by random number voting method. Control group to implement routine nursing, observation group to implement cluster nursing. After 3 weeks of nursing intervention, pulmonary infection was compared, the time of admission to neurosurgical intensive care unit and the length of stay were counted, and the whole treatment cost was compared.Results The incidence of pulmonary infection in the observation group was 5.00%(2/40), while that in the control group was 27.50%(11/40), which was lower in the observation group than in the control group(χ~2=4.485, P <0.05). In the observation group, the ICU stay was(7.50±1.55) d, the length of stay was(13.50±1.50) d, and the hospitalization cost was(1.25±0.25) ten thousand yuan, which was shorter than that of the control group(t=9.945, 10.585, P<0.05), and the expense was also significantly lower than that of the control group(t=6.887, P<0.05). Conclusion Cluster nursing intervention can significantly reduce the probability of pulmonary infection, shorten the recovery time and reduce the cost of hospitalization in patients with lower respiratory tract multi-drug-resistant bacteria in tracheotomy.